Michael Reardon

Title: Michael Reardon: Innovator in Gene Expression Inhibition

Introduction

Michael Reardon is a notable inventor based in Westwood, MA (US). He has made significant contributions to the field of gene expression inhibition through his innovative research and patents. His work focuses on enhancing the efficacy of miRNA blocking compounds, which has important implications in biotechnology and medicine.

Latest Patents

Michael Reardon holds a patent titled "Compositions for inhibiting gene expression and uses thereof." This patent addresses the means for providing more efficacious miRNA blocking compounds. The inventors have discovered new structural features that surprisingly improve the efficacy of miRNA blocking molecules. These features include the presence of multiple 3' ends and a linker at the 5' ends. Surprisingly, these features improve the efficacy of the gene expression blocking compounds in a manner that decreases the compound's biologic instability. Even more surprisingly, this effect has been found to be applicable to both DNA and RNA oligonucleotide-based compounds and to have application in traditional antisense and RNAi technology. Michael Reardon has 1 patent to his name.

Career Highlights

Michael Reardon is currently associated with Idera Pharmaceuticals, Inc., where he continues to contribute to advancements in gene therapy and molecular biology. His work at Idera Pharmaceuticals has positioned him as a key player in the development of innovative therapeutic solutions.

Collaborations

Michael has collaborated with notable colleagues, including Ireneusz Nowak and Tao Lan. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Michael Reardon is a distinguished inventor whose work in gene expression inhibition has the potential to revolutionize therapeutic approaches in biotechnology. His innovative contributions continue to pave the way for advancements in the field.